+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Low-income Medicare beneficiaries and their experiences with the part D prescription drug benefit



Low-income Medicare beneficiaries and their experiences with the part D prescription drug benefit



Inquiry 47(2): 162-172



This study seeks to understand how much beneficiaries knew about the Medicare prescription drug benefit (Part D) and low-income subsidy (LIS) programs and what their experiences were with the programs. Part D enrollees who automatically qualified for the LIS were less likely to report awareness that they could switch among different plans, had lower knowledge scores, and were more likely to have medications not covered by the plan compared to beneficiaries who applied for the LIS and others who enrolled in Part D but did not receive the LIS. Communication efforts to the LIS population, particularly for beneficiaries deemed automatically eligible for the LIS, need to continually make them aware of their benefits and protections in Part D.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054189937

Download citation: RISBibTeXText

PMID: 20812464

DOI: 10.2307/23035423


Related references

Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit. Journal of the American Pharmacists Association 49(1): 18-25, 2009

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement. Bmc Health Services Research 14(): 665-665, 2016

Structure of prescription drug benefit may help Medicare beneficiaries budget prescription drug costs more effectively. Findings Brief 4(5): 1-3, 2002

The New Medicare Part D Prescription Drug Benefit: An Estimation of Its Effect on Prescription Drug Costs in a Medicare Population with Atrial Fibrillation. Yearbook of Cardiology 2008: 498-499, 2008

The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation. Journal of the American Geriatrics Society 55(7): 1038-1043, 2007

Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule. Federal Register 77(8): 1877-1883, 2012

Designing a prescription drug benefit for rural Medicare beneficiaries:. 2000

Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit. Medical Care 48(3): 267-272, 2010

Iowa medicare beneficiaries' satisfaction and experiences with a prescription drug discount card and preferred drug list. Journal of the American Pharmacists Association 46(6): 715-722, 2006

Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act. Medical Care 55(1): 43-49, 2016

Psychometric properties of an instrument to assess Medicare beneficiaries' prescription drug plan experiences. Health Care Financing Review 30(3): 41-53, 2009

Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit. American Journal of Health-System Pharmacy 64(15 Suppl 10): S3-6; Quiz S21-S23, 2007

Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA 299(16): 1929-1936, 2008

Regulations regarding income-related monthly adjustment amounts to Medicare beneficiaries' prescription drug coverage premiums. Final rule. Federal Register 77(143): 43496-8, 2012

The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures. Journal of Investigative Medicine 56(3): 620, 2008